RESEARCH, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT by and between EPIX Pharmaceuticals, Inc. and Cystic Fibrosis Foundation Therapeutics, Inc.Development and Commercialization Agreement • May 9th, 2008 • EPIX Pharmaceuticals, Inc. • Pharmaceutical preparations • Maryland
This Agreement (as defined below) is made as of this 1st day of April, 2008 (the “Effective Date”) by and between EPIX Pharmaceuticals, Inc. (“EPIX”), a Delaware corporation with its principal office at 4 Maguire Road, Lexington, MA 02421, and Cystic Fibrosis Foundation Therapeutics, Inc., a Maryland corporation with its principal offices at 6931 Arlington Road, Bethesda, MD 20814 (“CFFT”), and shall become effective on the Effective Date (as defined below). EPIX and CFFT are each a “Party,” and, collectively, the “Parties.”
